"Voglibose & Metformin Combo: Diabetes Management Tips"

May 25, 2024

VOGLIGOLD M 0.2 

Voglibose 0.2 mg + Metformin SR 500

Introduction

Voglibose 0.2 mg and Metformin SR 500, marketed under the brand name VOGLIGOLD M 0.2, is a combination medication used for managing type 2 diabetes. This medication leverages the benefits of both Voglibose and Metformin to effectively control blood sugar levels and improve insulin sensitivity.

Uses

  • Type 2 Diabetes Management: VOGLIGOLD M 0.2 is primarily prescribed to improve glycemic control in adults with type 2 diabetes. It helps lower blood sugar levels post-meal and enhances the body's response to insulin.
  • Dual Action: Voglibose, an alpha-glucosidase inhibitor, delays the absorption of carbohydrates in the intestines, reducing postprandial blood sugar spikes. Metformin, a biguanide, decreases hepatic glucose production and improves insulin sensitivity.
  • Preventing Complications: Effective blood sugar management with VOGLIGOLD M 0.2 helps prevent diabetes-related complications such as neuropathy, nephropathy, and cardiovascular issues.

Dosage

  • Standard Dosage: The typical dosage of VOGLIGOLD M 0.2 is one tablet taken once or twice daily, depending on the patient's needs and response to treatment.
  • Administration: It is usually taken orally, with meals to reduce gastrointestinal side effects and enhance absorption.
  • Consistency: Maintaining a regular dosing schedule is crucial for achieving optimal blood sugar control.

Side Effects

  • Common Side Effects: Some common side effects include gastrointestinal discomfort such as nausea, diarrhea, stomach pain, and flatulence.
  • Serious Side Effects: Although rare, serious side effects include lactic acidosis (a buildup of lactic acid in the blood), severe allergic reactions, and liver problems. Immediate medical attention is required if these symptoms occur.
  • Monitoring: Regular blood glucose monitoring and periodic blood tests are essential to ensure the medication’s effectiveness and safety.

Precautions

  • Medical History: Inform your doctor of any medical history, particularly kidney or liver disease, heart problems, or a history of allergic reactions.
  • Pregnancy and Breastfeeding: VOGLIGOLD M 0.2 should be used during pregnancy only if clearly needed and prescribed by your doctor. Consult your doctor before breastfeeding.
  • Interactions: Provide a list of all medications, supplements, and herbal products you are taking to avoid potential interactions.

Conclusion

Voglibose 0.2 mg and Metformin SR 500, known as VOGLIGOLD M 0.2, is an effective combination medication for managing type 2 diabetes. By following the prescribed dosage and maintaining regular monitoring, patients can significantly improve their blood sugar control and overall health. Always consult with your healthcare provider for personalized advice and report any unusual symptoms promptly.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 

 

 

SHARE WITH